Dexmedetomidine
HealthData.Gov
Updated Oct 29, 2026
About this dataset
IGALMI is a prescription medication containing dexmedetomidine, available as a sublingual film in 120 mcg and 180 mcg doses. Manufactured by BioXcel Therapeutics, Inc., it acts as a central alpha-2 adrenergic agonist and is used for general anesthesia. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dexmedetomidine
Access the FDA dataset for Dexmedetomidine — ANDA 205046 submitted by Mylan Institutional LLC
Modified Apr 29, 2026